|
Scientific articles
The science behind CXL and PACK-CXL
|
High fluence PACK-CXL is better than low fluence PACK-CXL
EMAGine
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment for infectious keratitis and corneal
Landmark PACK-CXL trial published
EMAGine
This month, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection therapy.
US Ophthalmic Review reviews CXL at the Slit Lamp
EMAGine
Prof. Hafezi reviews the CXL at the Slit Lamp technique in US Ophthalmic Review
Journal of Refractive Surgery publishes CXL at the Slit Lamp technique
EMAGine
Nikki Hafezi’s successful launch of slit lamp cross-linking technology.
Power up! More UV needed to treat IK
EMAGine
PACK-CXL for infectious keratitis is not like treating keratoconus with CXL.
